Sustained low global respiratory virus activity, with SARS-CoV-2 and influenza positivity remaining below 10% in most regions according to recent WHO surveillance, underpins trader consensus that no new pandemic will emerge in 2026. The large Bundibugyo virus Ebola outbreak in the Democratic Republic of the Congo, exceeding 11,000 confirmed cases with regional exports to Kenya and Nigeria, has been designated a public health emergency of international concern yet shows slowing transmission in monitored areas and no evidence of sustained intercontinental spread. Ongoing monitoring of variants like PJ.2.1 reveals no increased severity, while other events such as measles surges or limited avian influenza detections remain below pandemic thresholds. Realistic shifts could occur if insecurity disrupts Ebola containment, a novel zoonotic pathogen achieves efficient human transmission, or an undetected respiratory variant drives rapid global escalation before December.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated1H6H1D7D30DALL
View resolved

Beware of external links.
Beware of external links.
Frequently Asked Questions